Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C18H19NO3 |
| Molecular Weight | 297.3484 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12OC3=C(O)C=CC4=C3[C@@]15CCN(C)[C@]([H])(C4)C5=CC=C2OC
InChI
InChIKey=ZKLXUUYLEHCAMF-UUWFMWQGSA-N
InChI=1S/C18H19NO3/c1-19-8-7-18-11-4-6-14(21-2)17(18)22-16-13(20)5-3-10(15(16)18)9-12(11)19/h3-6,12,17,20H,7-9H2,1-2H3/t12-,17+,18+/m1/s1
| Molecular Formula | C18H19NO3 |
| Molecular Weight | 297.3484 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist. | 2001 May |
|
| Characterization of opiates, neuroleptics, and synthetic analogs at ORL1 and opioid receptors. | 2001 Sep 28 |
|
| Separation of opiate alkaloids by electrokinetic chromatography with sulfated-cyclodextrin as a pseudo-stationary phase. | 2003 Jan 24 |
|
| A rapid and reliable solid-phase extraction method for high-performance liquid chromatographic analysis of opium alkaloids from papaver plants. | 2005 Nov |
|
| Rapid determination of Papaver somniferum alkaloids in process streams using monolithic column high-performance liquid chromatography with chemiluminescence detection. | 2007 Jul 30 |
|
| Cinnamoyl derivatives of 7alpha-aminomethyl-6,14-endo-ethanotetrahydrothebaine and 7alpha-aminomethyl-6,14-endo-ethanotetrahydrooripavine and related opioid ligands. | 2007 Oct 18 |
|
| Designation of oripavine as a basic class of controlled substance. Final rule. | 2007 Sep 24 |
|
| A hybrid FIA/HPLC system incorporating monolithic column chromatography. | 2007 Sep 26 |
|
| Biochemistry and occurrence of o-demethylation in plant metabolism. | 2010 |
|
| N-demethylation of N-methyl alkaloids with ferrocene. | 2010 Aug 1 |
|
| No hyperalgesia following opioid withdrawal after the oripavine derivative etorphine compared to remifentanil and sufentanil. | 2010 Feb |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:31:19 GMT 2023
by
admin
on
Sat Dec 16 08:31:19 GMT 2023
|
| Record UNII |
575AOU51CR
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DEA NO. |
9330
Created by
admin on Sat Dec 16 08:31:19 GMT 2023 , Edited by admin on Sat Dec 16 08:31:19 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
467-04-9
Created by
admin on Sat Dec 16 08:31:19 GMT 2023 , Edited by admin on Sat Dec 16 08:31:19 GMT 2023
|
PRIMARY | |||
|
DTXSID10196908
Created by
admin on Sat Dec 16 08:31:19 GMT 2023 , Edited by admin on Sat Dec 16 08:31:19 GMT 2023
|
PRIMARY | |||
|
m8232
Created by
admin on Sat Dec 16 08:31:19 GMT 2023 , Edited by admin on Sat Dec 16 08:31:19 GMT 2023
|
PRIMARY | Merck Index | ||
|
5462306
Created by
admin on Sat Dec 16 08:31:19 GMT 2023 , Edited by admin on Sat Dec 16 08:31:19 GMT 2023
|
PRIMARY | |||
|
8324
Created by
admin on Sat Dec 16 08:31:19 GMT 2023 , Edited by admin on Sat Dec 16 08:31:19 GMT 2023
|
PRIMARY | |||
|
ORIPAVINE
Created by
admin on Sat Dec 16 08:31:19 GMT 2023 , Edited by admin on Sat Dec 16 08:31:19 GMT 2023
|
PRIMARY | |||
|
207-385-6
Created by
admin on Sat Dec 16 08:31:19 GMT 2023 , Edited by admin on Sat Dec 16 08:31:19 GMT 2023
|
PRIMARY | |||
|
575AOU51CR
Created by
admin on Sat Dec 16 08:31:19 GMT 2023 , Edited by admin on Sat Dec 16 08:31:19 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
For the calculation of contents, multiply the peak areas by 0.4
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
